CDT

NASDAQ Healthcare

CDT Equity Inc. - Common Stock

Biotechnology

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

�� 市场数据
价格$0.17
成交量17,420,300
市值2.38M
贝塔系数1.450
200日均线$122.44
50日均线$2.37
52周最高$1778.00
52周最低$0.16
在Yahoo Finance查看 →
🎯 投资策略评分

CDT 在各投资策略中的评分。分数越高，越符合该策略目标。

💰 Dividend Daddy 15/100
高股息率 + 低波动性
🚀 Moon Shot 94/100
高增长潜力（高贝塔 + 超卖）
🔪 Falling Knife 99/100
逆向投资（超卖 + 低于移动均线）
🔍 策略解读

最佳匹配： 🔪 Falling Knife (99/100) — 此策略 逆向投资（超卖 + 低于移动均线）.

评分最低的策略： 💰 Dividend Daddy (15/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →

📚 了解更多
本页指标
教育文章
网站资源
在文本中查找 CDT in your text

粘贴任何文章、记录或帖子 — 工具将提取 CDT 以及每一个其他隐藏的股票代码。

试试股票代码提取器 →

免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-09-18.